Exercise and the growth hormone-insulin-like growth factor axis

Medicine and Science in Sports and Exercise

Volumn 42, Issue 1, 2010, Pages 58-66

  Frystyk, Jan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bioactive IGF I; Endocrine IGF I; Free IGF I; IGF binding proteins; Paracrine autocrine IGF I

Indexed keywords

ANIMALS; EXERCISE; GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MUSCLE STRENGTH; MUSCLE, SKELETAL;

EID: 73449114573     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3181b07d2d     Document Type: Review

References (75)

1. Adams GR, Haddad F. The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol. 1996;81(6):2509-2516
2. Alemany JA, Nindl BC, Kellogg MD, Tharion WJ, Young AJ, Montain SJ. Effects of dietary protein content on IGF-I, testosterone, and body composition during 8 days of severe energy deficit and arduous physical activity. J Appl Physiol. 2008;105(1):58-64.
3. Berg U, Gustafsson T, Sundberg CJ, Kaijser L, Carlsson-Skwirut C, Bang P. Interstitial IGF-I in exercising skeletal muscle in women. Eur J Endocrinol. 2007;157(4):427-435
4. Bermon S, Ferrari P, Bernard P, Altare S, Dolisi C. Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol Scand. 1999;165(1):51-56
5. Brat O, Ziv I, Klinger B, Avraham M, Laron Z. Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome. Horm Res. 1997;47(2):45-48
6. Brismar K, Fernqvist Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab. 1994;79(3):872-878
7. Brugts MP, Ranke MB, Hofland LJ, et al. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immuno-assays. J Clin Endocrinol Metab. 2008;93(7):2539-2545
8. Chen JW, HLjlund K, Beck-Nielsen H, Sandahl CJ, Krskov H, Frystyk J. Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects. J Clin Endocrinol Metab. 2005;90(1): 366-371
9. Chen JW, Ledet T, Krskov H, et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab. 2003;284(6):E1149-55.
10. Chicharro JL, Lopez-Calderon A, Hoyos J, et al. Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3. Br J Sports Med. 2001;35(5):303-307
11. Christensen SE, JLrgensen OL, MLller N, Krskov H. Characterization of growth hormone release in response to external heating. Comparison to exercise induced release. Acta Endocrinol (Copenh). 1984;107(3):295-301.
12. Clemmons DR. Commercial assays available for insulin-like growth factor I and their use in diagnosing growth hormone deficiency. Horm Res. 2001;55(Suppl 2):73-79
13. Clemmons DR. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov. 2007;6(10):821-833
14. Coleman ME, DeMayo F, Yin KC, et al. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem. 1995;270(20):12109-12116
15. Dall R, Lange KHW, Kjær M, et al. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. J Clin Endocrinol Metab. 2001; 86(2):669-674
16. De Palo EF, Antonelli G, Gatti R, Chiappin S, Spinella P, Cappellin E. Effects of two different types of exercise on GH/IGF axis in athletes. Is the free/total IGF-I ratio a new investigative approach? Clin Chim Acta. 2008;387(1-2):71-74
17. Desvigne N, Barthelemy JC, Frere D, Gay-Montchamp JP, Costes F. Microdialysis of insulin-like growth factor-I in human muscle. Eur J Appl Physiol. 2005;94(1):216-219
18. Domene HM, Martinez AS, Frystyk J, et al. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor I in a patient with acid-labile subunit deficiency. Horm Res. 2007;67(5):243-249
19. Eliakim A, Brasel JA, Mohan S, Barstow TJ, Berman N, Cooper DM. Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. J Clin Endocrinol Metab. 1996;81(11):3986-3992
20. Eliakim A, Brasel JA, Mohan S, Wong WL, Cooper DM. Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am J Physiol. 1998;275(1 Pt 2):R308-14.
21. Frystyk J. Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeosta-sis. Growth Horm IGF Res. 2004;14(5):337-375
22. Frystyk J. Utility of free IGF-I measurements. Pituitary. 2007; 10(2):181-187
23. Frystyk J, Ivarsen P, StLving RK, et al. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay. Growth Horm IGF Res. 2001;11(2):117-127
24. Frystyk J, Skjærbæk C, Dinesen B, Krskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 1994;348(2):185-191
25. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977;60(3): 648-657
26. Gibney J, Healy ML, Sonksen PH. The growth hormone/insulinlike growth factor-I axis in exercise and sport. Endocr Rev. 2007; 28(6):603-624
27. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19(6):717-797
28. Hagberg JM, Seals DR, Yerg JE, et al. Metabolic responses to exercise in young and older athletes and sedentary men. J Appl Physiol. 1988;65(2):900-908
29. Hambrecht R, Schulze PC, Gielen S, et al. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2005;12(4):401-406 (Pubitemid 41192174)
30. Hedman CA, Frystyk J, Lindström T, et al. Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. J Clin Endocrinol Metab. 2004;89(12):6305-6309
31. Holt RI, Webb E, Pentecost C, Sonksen PH. Aging and physical fitness are more important than obesity in determining exercise-induced generation of GH. J Clin Endocrinol Metab. 2001;86(12): 5715-5720
32. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73(5):1081-1088
33. Jenkins PJ. Growth hormone and exercise. Clinl Endocrinol (Oxford). 1999;50(6):683-689
34. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995; 16(1):3-34.
35. Kanaley JA, Frystyk J, MLller N, et al. The effect of submaximal exercise on immuno-and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects. Growth Horm IGF Res. 2005;15(4):283-290
36. Kanaley JA, Weatherup-Dentes MM, Jaynes EB, Hartman ML. Obesity attenuates the growth hormone response to exercise. J Clin Endocrinol Metab. 1999;84(9):3156-3161
37. Kanaley JA, Weltman JY, Veldhuis JD, Rogol AD, Hartman ML, Weltman A. Human growth hormone response to repeated bouts of aerobic exercise. J Appl Physiol. 1997;83(5):1756-1761
38. Kim H, Barton E, Muja N, Yakar S, Pennisi P, LeRoith D. Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology. 2005;146(4):1772-1779
39. Koistinen H, Koistinen R, Selenius L, Ylikorkala Q, Seppala M. Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. J Appl Physiol. 1996;80(3):760-764
40. Koziris LP, Hickson RC, Chatterton RT Jr, et al. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol. 1999;86(4):1436-1442
41. LeRoith D, Bondy C, Yakar S, Liu JL, Butler A. The so-matomedin hypothesis: 2001. Endocr Rev. 2001;22(1):53-74.
42. LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab. 2007;3(3):302-310
43. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endo-crinol Metab. 2000;85(12):4712-4720
44. Maccario M, Tassone F, Gauna C, et al. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol. 2001;144(3):251-256
45. Matheny W, Merritt E, Zannikos SV, Farrar RP, Adamo ML. Serum IGF-I-deficiency does not prevent compensatory skeletal muscle hypertrophy in resistance exercise. Exp Biol Med. 2009; 234(2):164-170
46. Nemet D, Oh Y, Kim HS, Hill M, Cooper DM. Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics. 2002;110(4):681-689
47. Nemet D, Connolly PH, Pontello-Pescatello AM, et al. Negative energy balance plays a major role in the IGF-I response to exercise training. J Appl Physiol. 2004;96(1):276-282
48. Nindl BC, Headley SA, Tuckow AP, et al. IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients. Growth Horm IGF Res. 2004;14(3):245-250
49. Nindl BC, Kraemer WJ, Marx JO, et al. Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol. 2001;90(4):1319-1326
50. Olesen JL, Heinemeier KM, Gemmer C, Kjær M, Flyvbjerg A, Langberg H. Exercise-dependent IGF-I, IGFBPs, and type I collagen changes in human peritendinous connective tissue determined by microdialysis. J Appl Physiol. 2007;102(1):214-220
51. Payet LD, Firth SM, Baxter RC. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J Clin Endocrinol Metab. 2004;89(5):2382-2389
52. Poehlman ET, Copeland KC. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab. 1990;71(6):1468-1473
53. Poehlman ET, Rosen CJ, Copeland KC. The influence of endurance training on insulin-like growth factor-1 in older individuals. Metabolism. 1994;43(11):1401-1405
54. Pritzlaff CJ, Wideman L, Weltman JY, et al. Impact of acute exercise intensity on pulsatile growth hormone release in men. J Appl Physiol. 1999;87(2):498-504.
55. Pritzlaff-Roy CJ, Widemen L, Weltman JY, et al. Gender governs the relationship between exercise intensity and growth hormone release in young adults. J Appl Physiol. 2002;92(5): 2053-2060
56. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkeb&k NE. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab. 1995;80(4): 1407-1415
57. Rosendal L, Langberg H, Flyvbjerg A, Frystyk J, Krskov H, Kjær M. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol. 2002;93(5):1669-1675
58. Roth J, Glick SM, Yalow RS, Berson SA. Secretion of human growth hormone: physiologic and experimental modification. Metabolism. 1963;12(7):577-579
59. Sadick MD. Kinase receptor activation (KIRA): a rapid and accurate alternative to endpoint bioassays. Dev Biol Stand. 1999; 97:121-133
60. Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM. Acute effect of brief low-and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab. 1996;81(10):3492-3497
61. Skjærbæk C, Frystyk J, Krskov H, et al. Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis. J Clin Endocrinol Metab. 1998; 83(7):2445-2449
62. Stokes K. Growth hormone responses to sub-maximal and sprint exercise. Growth Horm IGF Res. 2003;13(5):225-238 (Pubitemid 37161677)
63. Stokes K, Nevill M, Frystyk J, Lakomy H, Hall G. Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts. J Appl Physiol. 2005; 99(4):1254-1261
64. Stokes KA, Nevill ME, Cherry PW, Lakomy HK, Hall GM. Effect of 6 weeks of sprint training on growth hormone responses to sprinting. Eur J Appl Physiol. 2004;92(1-2):26-32.
65. Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y. Measurement of free insulin-like growth factor-I using immunoradiometric assay. J Immunoassay. 1994;15(3): 263-276
66. Vahl N, Jlrgensen JO, Jurik AG, Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab. 1996;81(6):2209-2215
67. Vahl N, JLrgensen JO, Skj&rb&k C, Veldhuis JD, Krskov H, Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol. 1997;272(6 Pt 1):E1108-16.
68. Velloso CP. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol. 2008;154(3):557-568
69. Wallace JD, Cuneo RC, Baxter R, et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab. 1999;84(10):3591-3601
70. Weltman A, Weltman JY, Schurrer R, Evans WS, Veldhuis JD, Rogol AD. Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity. J Appl Physiol. 1992;72(6):2188-2196
71. Weltman A, Weltman JY, Watson Winfield DD, et al. Effects of continuous vs intermittent exercise, obesity, and gender on growth hormone secretion. J Clin Endocrinol Metab. 2008; 93(12):4711-4720
72. Wideman L, Consitt L, Patrie J, et al. The impact of sex and exercise duration on growth hormone secretion. J Appl Physiol. 2006;101(6):1641-1647
73. Wideman L, Weltman JY, Hartman ML, Veldhuis JD, Weltman A. Growth hormone release during acute and chronic aerobic and resistance exercise: recent findings. Sports Med. 2002;32(15): 987-1004.
74. Yakar S, Rosen CJ, Bouxsein ML, et al. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J. 2009;23(3):709-719
75. Zanconato S, Moromisato DY, Moromisato MY, et al. Effect of training and growth hormone suppression on insulin-like growth factor I mRNA in young rats. J Appl Physiol. 1994; 76(5):2204-2209 (Pubitemid 24158658)